Univariate- and machine learning-based plasma metabolite signature differentiates PSC-IBD from IBD and is predicted to be driven by gut microbial changes
Joanna C. Wolthuis, Johannes P. D. Schultheiss, Stefanía Magnúsdóttir, Edwin C.A. Stigter et autres
INTRODUCTION: Inflammatory bowel disease (IBD) is a group of chronic inflammatory conditions of the gastrointestinal tract comprising two major phenotypes, Crohn's disease (CD) and ulcerative colitis (UC). Up to 8% of patients with IBD also develop primary sclerosing cholangitis (PSC), characterised by …
nl (code pays fourni par la source)